Advertisement
Despite aggressive surgical intervention and new chemotherapeutic regimens, the overall five-year survival rate for women with advanced stage epithelial ovarian cancer (EOC) (stages III and IV) remains poor (<30%). However, if EOC is detected when confined t o the ovary (stage I), the 5-year survival rate is more than 90%, it requires less radical and morbid operations and may not require adjuvant chemotherapy. Clearly, detection of early stage ovarian cancer is the best way to improve survival.
Continue Learning about Ovarian Cancer
Important: This content reflects information from various individuals and organizations and may offer alternative or opposing points of view. It should not be used for medical advice, diagnosis or treatment. As always, you should consult with your healthcare provider about your specific health needs.